PLN695.00
0.87% yesterday
Warsaw, Jun 27, 04:48 pm CET
ISIN
PLTRFRM00018
Symbol
NEU

Neuca Stock price

PLN694.00
-25.00 3.48% 1M
-181.00 20.69% 6M
-179.00 20.50% YTD
-232.00 25.05% 1Y
-70.98 9.28% 3Y
+215.07 44.91% 5Y
+453.74 188.85% 10Y
+670.18 2,813.96% 20Y
Warsaw, Closing price Fri, Jun 27 2025
+5.00 0.73%
ISIN
PLTRFRM00018
Symbol
NEU
Sector

Key metrics

Basic
Market capitalization
PLN3.1b
Enterprise Value
PLN3.6b
Net debt
PLN477.8m
Cash
PLN157.9m
Shares outstanding
4.6m
Valuation (TTM | estimate)
P/E
21.74 | 12.56
P/S
0.24 | 0.23
EV/Sales
0.28 | 0.26
EV/FCF
323.32
P/B
2.75
Dividends
DPS
PLN16.00
Yield 1Y | 5Y
2.31% | 1.87%
Growth 1Y | 5Y
10.34% | 13.09%
Payout 1Y | 3Y
47.04% | 45.08%
Increased
19 Years
Financials (TTM | estimate)
Revenue
PLN12.8b | PLN13.6b
EBITDA
PLN390.4m | PLN515.8m
EBIT
PLN268.1m
Net Income
PLN146.2m | PLN251.4m
Free Cash Flow
PLN11.1m
Growth (TTM | estimate)
Revenue
7.04% | 7.59%
EBITDA
-1.53% | 30.40%
EBIT
-4.39%
Net Income
-5.65% | 62.97%
Free Cash Flow
-94.37%
Margin (TTM | estimate)
Gross
11.46%
EBITDA
3.05% | 3.80%
EBIT
2.09%
Net
1.14% | 1.85%
Free Cash Flow
0.09%
Financial Health
Equity Ratio
20.67%
Return on Equity
13.54%
ROCE
15.36%
ROIC
9.59%
Debt/Equity
0.55
More
EPS
PLN31.93
FCF per Share
PLN2.44
Short interest
-
Employees
4.63k
Rev per Employee
PLN2.72m
Show more

Is Neuca a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Neuca Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Neuca forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Neuca forecast:

Buy
75%
Hold
25%

Financial data from Neuca

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12,816 12,816
7% 7%
100%
- Direct Costs 11,347 11,347
7% 7%
89%
1,468 1,468
10% 10%
11%
- Selling and Administrative Expenses 1,204 1,204
12% 12%
9%
- Research and Development Expense - -
-
-
390 390
2% 2%
3%
- Depreciation and Amortization 122 122
5% 5%
1%
EBIT (Operating Income) EBIT 268 268
4% 4%
2%
Net Profit 146 146
6% 6%
1%

In millions PLN.

Don't miss a Thing! We will send you all news about Neuca directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NEUCA SA engages in the wholesale of pharmaceutical products. It operates through the following segments: Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials, and Telemedicine. The Pharmaceutical Wholesale segment provides medical products for pharmacies. The Own Brands segment comprises market launching of pharmaceutical products under own brand. The Outpatient Care Clinics, Clinical Trials, and Telemedicine segment activities include general medical practice, clinical trials, and telemedicine. The company was founded by Kazimierz Michal Herba in 1990 and is headquartered in Torun, Poland.

Head office Poland
CEO Piotr Sucharski
Employees 4,633
Founded 1990
Website www.neuca.pl

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today